undamentalytics Newsletter
Sign in

Neogen Corp cash flow statement

In fiscal 2026, Neogen Corp's operations generated $83.2m of cash; it spent $51.3m on capital projects, leaving free cash flow of $31.9m.

Cash flow statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2010May 20102011May 20112012May 20122013May 20132014May 20142015May 20152016May 20162017May 20172018May 20182019May 20192020May 20202021May 20212022May 20222023May 20232024May 20242025May 20252026May 2026LTMAug 2026
Cash from operations282922272244356069648681684135588385
Depreciation and amortisation45679111215171818212488117120116116
Stock-based pay22234455566671014171312
Capital spending5829121014152115242724661111055136
Free cash flow23212118103421464849625444−25−76−463250
Free cash flow after stock pay2019181563016404344554836−35−90−641938
Share buybacks—————————3————————

Free cash flow is cash from operations minus capital spending. Free cash flow after stock pay also subtracts stock-based compensation, a real cost to shareholders that the cash flow statement adds back. Dividends, buybacks and shares issued are cash amounts for the period.

Compare with peers

Head to head: INSP vs NEOGNEOG vs VREXATEC vs NEOG

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Neogen Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Neogen Corp.